tiprankstipranks
Trending News
More News >
Core Scientific Inc (CORZ)
NASDAQ:CORZ
US Market
Advertisement

Core Scientific Inc (CORZ) AI Stock Analysis

Compare
1,926 Followers

Top Page

CORZ

Core Scientific Inc

(NASDAQ:CORZ)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - 4o)
Rating:41Neutral
Price Target:
$14.50
▼(-5.78% Downside)
Core Scientific Inc. faces significant financial and technical challenges. The company's financial performance is weak, with declining revenues, negative profitability, and high debt levels. Technical analysis indicates a bearish trend, with the stock trading below key moving averages and oversold indicators. The stock is also overvalued based on its high P/E ratio. These factors contribute to a low overall stock score.
Positive Factors
Energy Efficiency
Energy-efficient operations reduce costs and enhance sustainability, providing a competitive edge in the energy-intensive crypto mining industry.
Strategic Partnerships
Strategic partnerships help optimize costs and enhance operational efficiency, supporting long-term growth and competitive positioning.
Growth Potential
Access to low-cost power and construction expertise positions Core Scientific to expand its infrastructure, supporting future growth opportunities.
Negative Factors
High Debt Levels
High debt levels can strain financial flexibility, increasing risk and potentially limiting future investment opportunities.
Declining Revenue
Declining revenue growth indicates challenges in market demand or competitive pressures, impacting long-term financial health.
Negative Free Cash Flow
Negative free cash flow suggests ongoing liquidity issues, which can hinder the company's ability to invest in growth and innovation.

Core Scientific Inc (CORZ) vs. SPDR S&P 500 ETF (SPY)

Core Scientific Inc Business Overview & Revenue Model

Company DescriptionCore Scientific Inc (CORZ) is a leading provider of blockchain infrastructure and cryptocurrency mining services. The company focuses on delivering large-scale, efficient, and sustainable solutions for cryptocurrency mining, primarily through its data centers that utilize advanced technologies. Core Scientific operates within the cryptocurrency and blockchain sector, providing services such as mining hardware hosting, blockchain-based software solutions, and energy management services, catering to both institutional and individual clients.
How the Company Makes MoneyCore Scientific generates revenue primarily through cryptocurrency mining operations and hosting services. The company earns money by mining various cryptocurrencies, particularly Bitcoin, leveraging its large-scale data centers that are optimized for energy efficiency. Additionally, Core Scientific offers hosting services for third-party miners, charging fees for space, power, and maintenance of mining equipment. Key revenue streams include direct cryptocurrency mining profits, hosting fees, and potentially software solutions designed for blockchain applications. Significant partnerships with hardware manufacturers and energy providers also contribute to its earnings, allowing Core Scientific to optimize costs and enhance operational efficiency.

Core Scientific Inc Earnings Call Summary

Earnings Call Date:May 07, 2025
(Q1-2025)
|
% Change Since: |
Next Earnings Date:Mar 31, 2026
Earnings Call Sentiment Neutral
The earnings call reflects a company in transition, making strategic infrastructure investments and aligning with CoreWeave to capitalize on AI demand. Despite revenue and EBITDA challenges, Core Scientific demonstrates strong progress in expanding capabilities and securing a leading market position.
Q1-2025 Updates
Positive Updates
Strategic Partnership with CoreWeave
CoreWeave contracts are foundational, with CoreWeave funding virtually all of the capital investment on deployments, keeping balance sheet leverage light and providing strategic flexibility.
Construction Progress and Capability Expansion
Significant progress in advancing 570 megawatts of billable capacity for CoreWeave, with notable achievements at the Denton facility, expected to be one of the largest GPU clusters in North America.
Strong Market Position in AI Infrastructure
Core Scientific positions itself as a leading provider of high-density infrastructure for AI workloads, leveraging dislocation in the market where traditional providers struggle to meet new demands.
Positive Large Enterprise Demand
Emerging demand from large enterprises for AI infrastructure, with potential deployments ranging from 50 to 100 megawatts, offering attractive return profiles.
Financial Strategy and Liquidity
$780 million liquidity position with minimal capital outlay on CoreWeave contracts, enabling strategic growth through traditional project financing structures.
Negative Updates
Revenue Decline
Total revenue for the quarter was $79.5 million, down 16% sequentially, primarily due to mining disconnections and relocations as sites are converted to support high-density colocation.
Negative Adjusted EBITDA
Adjusted EBITDA was negative $6.1 million for the quarter, reflecting challenges in transitioning from Bitcoin mining to datacenter operations.
No New Customer Signings
Despite an expanding sales pipeline, no new customer signings have been reported, though negotiations with multiple customers are ongoing.
Company Guidance
In the Core Scientific earnings call for the first quarter of fiscal year 2025, the company provided guidance on several key metrics and strategic initiatives. Core Scientific is focusing on diversifying its customer base and executing on its contracts with CoreWeave, with a goal to expand its billable capacity to 590 megawatts by early 2027. The company is also working to reduce CoreWeave's representation to less than 50% of its billable capacity by the end of 2028. The strategic partnership with CoreWeave is crucial, with CoreWeave funding almost all of the capital expenditures for these deployments, allowing Core Scientific to maintain a light balance sheet leverage and use debt strategically for future growth. The company reported a total revenue of $79.5 million for the quarter, a decrease of 16% sequentially, and an adjusted EBITDA of negative $6.1 million, primarily due to mining disconnections and relocations. Core Scientific plans to add approximately 300 megawatts of billable capacity across existing sites by the end of 2027 and aims to expand into new geographies, targeting an additional 400 megawatts of buildable capacity through new site development over the next three years.

Core Scientific Inc Financial Statement Overview

Summary
Core Scientific Inc. is facing significant financial challenges across all verticals. The income statement reflects declining revenues and negative profitability margins. The balance sheet is burdened with high debt and negative equity, raising concerns about financial stability. Cash flow improvements are overshadowed by persistent negative free cash flow, indicating liquidity constraints. The company needs to address these issues to improve its financial health and sustainability.
Income Statement
25
Negative
Core Scientific Inc. has experienced declining revenue growth, with a negative growth rate of -4.09% in the TTM period. The company is facing significant profitability challenges, as evidenced by negative net profit and EBIT margins. The gross profit margin has also decreased significantly from previous years, indicating pressure on cost management and pricing strategies.
Balance Sheet
20
Very Negative
The balance sheet reveals a concerning financial structure, with negative stockholders' equity and a high debt-to-equity ratio, indicating potential solvency issues. The return on equity is positive but misleading due to negative equity, suggesting that the company is operating at a loss. The equity ratio is negative, highlighting a reliance on debt financing.
Cash Flow
30
Negative
Cash flow analysis shows some improvement in free cash flow growth, but the company still reports negative free cash flow. The operating cash flow to net income ratio is positive, suggesting some ability to generate cash from operations, but the free cash flow to net income ratio remains negative, indicating ongoing cash flow challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue334.18M510.67M502.40M640.31M544.48M60.32M
Gross Profit21.78M121.07M123.46M8.40M238.86M9.39M
EBITDA-383.15M-1.16B-63.12M-1.84B140.79M1.63M
Net Income-768.31M-1.32B-246.49M-2.15B47.31M-12.21M
Balance Sheet
Total Assets2.30B1.60B712.16M807.69M2.44B225.58M
Cash, Cash Equivalents and Short-Term Investments453.44M836.20M50.41M15.88M117.87M8.67M
Total Debt1.06B1.20B865.54M37.73M818.81M40.29M
Total Liabilities3.42B2.42B1.31B1.22B1.10B91.88M
Stockholders Equity-1.13B-820.18M-596.94M-409.35M1.34B133.70M
Cash Flow
Free Cash Flow-354.09M-52.06M48.95M-396.47M-116.01M-25.33M
Operating Cash Flow138.99M42.90M65.11M205.19M-56.73M-23.77M
Investing Cash Flow-496.22M-95.19M-3.00M-590.78M-423.84M-15.14M
Financing Cash Flow556.88M819.57M-44.65M306.15M603.53M40.72M

Core Scientific Inc Technical Analysis

Technical Analysis Sentiment
Negative
Last Price15.39
Price Trends
50DMA
18.11
Negative
100DMA
16.11
Negative
200DMA
13.04
Positive
Market Momentum
MACD
-0.91
Positive
RSI
34.66
Neutral
STOCH
13.43
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CORZ, the sentiment is Negative. The current price of 15.39 is below the 20-day moving average (MA) of 18.82, below the 50-day MA of 18.11, and above the 200-day MA of 13.04, indicating a neutral trend. The MACD of -0.91 indicates Positive momentum. The RSI at 34.66 is Neutral, neither overbought nor oversold. The STOCH value of 13.43 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CORZ.

Core Scientific Inc Risk Analysis

Core Scientific Inc disclosed 88 risk factors in its most recent earnings report. Core Scientific Inc reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Core Scientific Inc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$3.80B25.0332.78%22.02%12.42%
75
Outperform
$3.09B7.2514.28%1.37%0.58%5.76%
69
Neutral
$1.94B28.739.79%10.58%-45.52%
68
Neutral
$2.94B34.949.51%19.28%6.16%
66
Neutral
$3.09B10.7023.10%7.25%-1.12%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
41
Neutral
$4.77B110.48-40.08%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CORZ
Core Scientific Inc
15.39
-2.16
-12.31%
EEFT
Euronet Worldwide
69.64
-35.28
-33.63%
SPSC
SPS Commerce
78.03
-108.29
-58.12%
PAGS
Pagseguro Digital
9.91
2.72
37.83%
PAYO
Payoneer
5.45
-5.33
-49.44%
DLO
DLocal
12.71
2.47
24.12%

Core Scientific Inc Corporate Events

Business Operations and StrategyM&A TransactionsShareholder Meetings
Core Scientific Terminates Merger Agreement with CoreWeave
Negative
Oct 31, 2025

On October 30, 2025, Core Scientific held a special meeting of stockholders to consider the merger with CoreWeave, Inc., but the proposal did not receive the necessary approval from stockholders. Consequently, Core Scientific terminated the Merger Agreement on the same day, impacting its strategic plans and future operations.

The most recent analyst rating on (CORZ) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on Core Scientific Inc stock, see the CORZ Stock Forecast page.

Business Operations and Strategy
Core Scientific to Present Strategic Growth Plans
Positive
Oct 30, 2025

Core Scientific, Inc. announced plans to present an investor presentation on or after October 30, 2025, highlighting its strategic growth and expansion in the digital infrastructure sector. The company is on track to energize 250 MW by the end of 2025 and 590 MW by early 2027, with significant contracts such as a 12-year agreement with CoreWeave valued at over $10 billion. This expansion is expected to strengthen Core Scientific’s market position and provide substantial economic benefits, with anticipated profit margins of 75% to 80%.

The most recent analyst rating on (CORZ) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on Core Scientific Inc stock, see the CORZ Stock Forecast page.

M&A TransactionsShareholder Meetings
Core Scientific Ends Merger with CoreWeave
Negative
Oct 30, 2025

On October 30, 2025, Core Scientific announced the termination of its merger agreement with CoreWeave due to insufficient stockholder votes. The company will continue to operate as a publicly traded entity on Nasdaq under the ticker symbol CORZ, maintaining its focus on digital infrastructure and high-density colocation services.

The most recent analyst rating on (CORZ) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on Core Scientific Inc stock, see the CORZ Stock Forecast page.

M&A TransactionsShareholder Meetings
Core Scientific Stockholders Reject CoreWeave Merger Proposal
Negative
Oct 30, 2025

On October 30, 2025, Core Scientific announced that its stockholders did not approve the proposed merger agreement with CoreWeave, Inc. during a special meeting held on the same day. This outcome may impact Core Scientific’s strategic plans and its positioning within the digital infrastructure industry, affecting stakeholders and potentially altering the company’s future operational focus.

The most recent analyst rating on (CORZ) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on Core Scientific Inc stock, see the CORZ Stock Forecast page.

Core Scientific Reports Q3 2025 Financial Results
Oct 27, 2025

Core Scientific, Inc., a leader in digital infrastructure for high-density colocation services and digital asset mining, operates dedicated facilities to provide digital infrastructure and software solutions to third-party customers.

Financial DisclosuresM&A Transactions
Core Scientific Reports Q3 2025 Revenue Decline
Negative
Oct 24, 2025

Core Scientific, Inc. reported its fiscal third quarter 2025 results, showing a decline in total revenue to $81.1 million from $95.4 million in the previous year. The company experienced a decrease in digital asset self-mining and hosted mining revenues, offset by an increase in high-density colocation revenue. Despite a net loss of $146.7 million, this was an improvement from the previous year’s loss due to smaller fair value adjustments. The company is also involved in a pending merger with CoreWeave, which would result in an all-stock transaction, subject to shareholder approval.

The most recent analyst rating on (CORZ) stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on Core Scientific Inc stock, see the CORZ Stock Forecast page.

Legal ProceedingsM&A Transactions
Core Scientific Faces Legal Challenges Over Merger
Negative
Oct 22, 2025

On July 7, 2025, Core Scientific, Inc. announced a merger with CoreWeave, Inc., where Core Scientific will become a wholly owned subsidiary of CoreWeave. This merger has led to legal challenges from some stockholders who allege disclosure deficiencies in the merger’s proxy statement/prospectus. Despite these allegations, Core Scientific and CoreWeave plan to supplement their disclosures to address these concerns, although they deny any legal necessity for additional disclosures.

The most recent analyst rating on (CORZ) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on Core Scientific Inc stock, see the CORZ Stock Forecast page.

Business Operations and StrategyM&A Transactions
Core Scientific Announces Merger with CoreWeave
Positive
Oct 15, 2025

Core Scientific, Inc. announced an updated investor presentation related to a proposed merger with CoreWeave, Inc., scheduled for a stockholder vote on October 30, 2025. The merger is expected to provide significant benefits, including risk reduction in data center delivery, a premium exchange ratio, and a substantial ownership stake in a leading AI platform. The merger aims to enhance Core Scientific’s market position by capitalizing on synergies and cost savings, while also expanding its addressable market in the AI infrastructure sector.

The most recent analyst rating on (CORZ) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Core Scientific Inc stock, see the CORZ Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 14, 2025